Results 241 to 250 of about 37,077 (282)

Erratum to "Mechanism of Action and Pharmacokinetics of Approved Bispecific Antibodies" [Biomol Ther 32(6), 708-722 (2024)]. [PDF]

Biomol Ther (Seoul)
Choi SM, Lee JH, Ko S, Hong SS, Jin HE.
europepmc   +1 more source

Updated transient gene expression protocol in Expi293F cells using PEI. [PDF]

Front Bioeng Biotechnol
Hederoth G, de la Rosa A, Godec A, Aguilar X, Napoleone A, Petrovic A, Metzendorf NG, Hultqvist G.   +7 more
europepmc   +1 more source

Functional NK engagers from OmniClic, a common light-chain platform producing fully human-sequence antibodies in a chicken host species. [PDF]

MAbs
Zeng B, Mechin I, Mowrey D, Rivera GS, Nyvall HG, Suresh S, Burke JE, Harriman W, Chen B, Abdiche Y.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Engineering bispecific antibodies

Current Opinion in Biotechnology, 1993
Bispecific antibodies have immense potential as reagents and in medicine. Until recently, they were made by combining monoclonal antibodies of two different specificities in vitro, or by fusion of the corresponding hybridomas. Protein engineering now offers the chance to construct a range of small 'designer' bispecific antibodies using antibody ...
P, Holliger, G, Winter
openaire   +2 more sources